NovaBridge Biosciences - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NovaBridge Biosciences - ADR
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
/ 
Others were interested in
Frequently asked questions
To buy NovaBridge Biosciences - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NovaBridge Biosciences - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NovaBridge Biosciences - ADR is NBP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NovaBridge Biosciences - ADR has its primary listing on NASDAQ. You can trade NovaBridge Biosciences - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NovaBridge Biosciences - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NovaBridge Biosciences - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NovaBridge Biosciences - ADR.